awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397708-1C84E072-4080-4381-B744-19E9F28C369C
Q33397708-1C84E072-4080-4381-B744-19E9F28C369C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397708-1C84E072-4080-4381-B744-19E9F28C369C
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.
P921
Q33397708-1C84E072-4080-4381-B744-19E9F28C369C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397708-1C84E072-4080-4381-B744-19E9F28C369C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0723282bb80042897ca697416c050b4bf7fb5428
P921
bevacizumab